You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotherapy

Showing 26 - 50 of 7,146
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

Not yet recruiting
  • Esophageal Carcinoma
  • Immune Checkpoint Inhibitors
  • (no location specified)
Jul 6, 2023

Minimally Residual of Esophageal Cancer 001

Recruiting
  • Esophageal Carcinoma
  • Minimal Residual Disease
    • Shijiazhuang, Hebei, China
      Fourth Hospital of Hebei Medical University
    Jul 17, 2023

    Patient Care Needs and Decision-Making Experience of Cancer and

    Active, not recruiting
    • Supportive Care Needs
    • Immunotherapy
      • Taipei, Taiwan
        National Taiwan University
      Feb 20, 2023

      Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H

      Recruiting
      • Colorectal Cancer
        • Shanghai, China
          Fudan University Shanghai Cancer Center
        Oct 18, 2023

        Metastatic Extracranial Malignant Solid Tumor, Radiotherapy, Immune Checkpoint Blockade Trial in Shantou (Intestinal Low Dose

        Not yet recruiting
        • Metastatic Extracranial Malignant Solid Neoplasm
        • +3 more
        • Intestinal Low Dose Radiotherapy-1Gy
        • +3 more
        • Shantou, Guangdong, China
          Cancer Hospital, Shantou University Medical College
        Oct 7, 2023

        Prognosis of Lung Cancer Immunotherapy

        Not yet recruiting
        • Lung Cancer
          • (no location specified)
          May 31, 2023

          Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

          Recruiting
          • Lung Cancer
            • Shanghai, China
              Shanghai Chest Hospital
            Jul 20, 2023

            Integrative Multi-Omics Testing for Immunotherapy Response in

            Recruiting
            • Lung Cancer
              • Guangzhou, Guangdong, China
                Nanfang hospital
              Jun 29, 2023

              Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

              Recruiting
              • Esophageal Squamous Cell Carcinoma
              • Split-course hypo-CCRT
              • +2 more
              • Guangzhou, Guangdong, China
                Sun yat-sen University Cancer Center
              Aug 26, 2023

              Efficacy and Safety of Cashew Nut Oral Immunotherapy in Children

              Not yet recruiting
              • Food Allergy in Children
              • no intervention
              • Vandœuvre-lès-Nancy, France
                Centre Hospitalo-Universitaire de Nancy
              Apr 7, 2023

              Physical Activity and Exercise in Cancer Immunotherapy Treatment

              Not yet recruiting
              • Cancer
              • Physical Activity and Exercise in Cancer Immunotherapy Treatment - Exploratory study of experiences and perceptions
              • (no location specified)
              Nov 22, 2023

              Predict the Response of Biliary Tract Tumors to Immunotherapy

              Recruiting
              • Biliary Tract Tumor
              • Cholangiocarcinoma
              • Blood samples, tumor biopsy specimens will be collected
              • Hangzhou, Zhejiang, China
                Zhejiang Cancer Hospital
              Sep 22, 2023

              Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)

              Recruiting
              • Liver Cancer
              • Autologous Tumor Infiltrating Lymphocytes
              • Wuhan, China
                Tongji Hospital
              Oct 9, 2023

              Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

              Recruiting
              • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
              • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
              • Shanghai, Shanghai, China
                Shanghai Renji Hospital
              Sep 12, 2023

              Selecting Patients Who May Benefit From Immunotherapy by

              Recruiting
              • Gastric Cancer Patients Received Immunotherapy
              • TIIC signature
              • Beijing, China
                Peking University Cancer Hospital
              Oct 21, 2022

              TRAQinform Assessment of Immunotherapy Response

              Not yet recruiting
              • Melanoma
              • Non-Interventional
              • (no location specified)
              Apr 6, 2023

              Food Allergy Trial in Netherlands (oral immunotherapy)

              Enrolling by invitation
              • Food Allergy
              • oral immunotherapy
              • Deventer, Overijssel, Netherlands
              • +3 more
              Feb 11, 2023

              Self Care, Symptom Management, Immunotherapy Trial in Ankara (TRAINING BOOKLET)

              Recruiting
              • Self Care
              • +3 more
              • TRAINING BOOKLET
              • Ankara, Turkey
                Ankara Medipol University
              Jan 4, 2023

              Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

              Not yet recruiting
              • Advanced Renal Cell Carcinoma
              • (no location specified)
              Jun 23, 2023

              Monitoring Allergen Immunotherapy in Allergic Rhinitis

              Recruiting
              • Immunotherapy
              • +2 more
              • A nasal fluid Basophil Activation Test (BAT)
              • Arnhem, Netherlands
                Rijnstate Hospital
              Nov 10, 2022

              Effects of Immunotherapy Trial in Zagazig (Sublingual immunotherapy)

              Completed
              • Effects of Immunotherapy
              • Sublingual immunotherapy
              • Zagazig, Egypt
                Fatma Zohry Kamel Khater
              Dec 18, 2022

              Quality of Life of Primary Solid Malignant Cancers Receiving

              Recruiting
              • Malignant Neoplasm
              • Solid tumor patients receiving immunotherapy for the first time were included in the study
              • Xi'an, Shanxi, China
                First Affiliated Hospitap of Xian Jiaotong University
              Feb 22, 2023

              Omitting Clinical Target Volume in Radical Treatment of

              Not yet recruiting
              • Immunotherapy
              • +3 more
              • IMRT+adjuvant immunotherapy
              • (no location specified)
              Jun 9, 2023

              Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

              Not yet recruiting
              • Nasopharyngeal Carcinoma
              • without concurrent cisplatin chemotherapy
              • with concurrent cisplatin chemotherapy
              • Fuzhou, Fujian, China
                Department of radiation oncology, Fujian cancer hospital
              Oct 18, 2023

              Allergy to Shrimp, Immunotherapy Trial in Bangkoknoi (shrimp allergy with intend to eat shrimp)

              Recruiting
              • Allergy to Shrimp
              • Immunotherapy
              • shrimp allergy with intend to eat shrimp
              • Bangkoknoi, Bangkok, Thailand
                Siriraj Hospital
              Sep 11, 2022